Analysis of the Exo(-) Mutant of Rhizobium huakuii and Their Exopolysaccharide Component.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)

Shanghai Institute of Plant Physiology, the Chinese Academy of Sciences, Shanghai 200032, China.

Published: January 1998

We have subcloned two plasmids, pWS-6BP1 and pWS-6BP2, from the 8.5 kb DNA fragment of plasmid pJB22-B6. The plasmid of pWS-6BP1, with a 5.8 kb DNA fragment, can complement the exopolysaccharide-deficient mutant NA06 and NA12 of Rhizobium huakuii strain 107, but the plasmid pWS-6BP2, with a 2.6 kb DNA fragment can only complement NA12. The effective nodules formed by the wild type strain 107 (Rh107) contain lots of bacteriods; the ineffective nodules formed by the mutant NA06 and NA12 contain few bacteroids. Although the nodule formed by Exo(+) transconjugants are ineffective, the bacteria can be successfully released into the cells and form lots of bacteroids. The Rh107 produces acidic exopolysaccharides (EPS) of high molecular weight (HMW) in large amount with only small amount of low molecular weight (LMW) forms. EPS secreted by mutants NA06 and NA12 are just the other way round with LMW in higher amount than HMW ones. They also produce an EPS with molecular weight in between. The EPS secreted by the Exo(+) transconjugants is more like the EPS of Rh107 than that of mutants, although their component and structure are still different from that of Rh107.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dna fragment
12
na06 na12
12
molecular weight
12
rhizobium huakuii
8
pws-6bp2 dna
8
fragment complement
8
mutant na06
8
strain 107
8
nodules formed
8
exo+ transconjugants
8

Similar Publications

Probiotics are widely used for their health promoting effects, though a lot remain to be discovered, particularly on their mechanisms of action at the molecular level. The functional genomic approach is an appropriate method to decipher how probiotics may influence human cell fate and therefore contribute to their health benefit. In the present work, we focused on Shouchella clausii (formerly named Bacillus then Alkalihalobacillus clausii), a spore-forming bacterium that is commercially available as a probiotic for the prevention and the treatment of intestinal dysbiosis and related gastrointestinal disorders, such as diarrhoea.

View Article and Find Full Text PDF

Tuberculosis (TB) is the second deadliest infectious disease worldwide. Current TB diagnostics utilize sputum samples, which are difficult to obtain, and sample processing is time-consuming and difficult. This study developed an integrated diagnostic platform for the rapid visual detection of Mycobacterium tuberculosis (Mtb) in breath samples at the point-of-care (POC), especially in resource-limited settings.

View Article and Find Full Text PDF

Effect of in vitro exposure of first-line antiretrovirals on healthy human spermatozoa on kinematics and motility.

Int Urol Nephrol

January 2025

Department of Urology, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa.

Purpose: Contemporary antiretroviral (ARV) medications are used by millions of men for HIV treatment worldwide. Limited data exist on their direct effect on sperm motility. This pilot study hypothesizes that in vitro exposure to ARVs will reduce sperm kinematic and motility parameter values.

View Article and Find Full Text PDF

Background: The common APOE2/E3/E4 polymorphism, the strongest risk factor for Alzheimer's disease (AD), is determined by two-site haplotypes at codons 112 (Cys>Arg) and 158 (Arg>Cys), resulting into six genotypes. Due to strong linkage disequilibrium between the two sites, 3 of the 4 expected haplotypes (E2, E3, E4) have been observed and extensively studied in relation to AD risk. Compared to the most common haplotype of E3 (Cys112 - Arg158), E4 (Arg112 - Arg 158) and E2 (Cys112 - Cys158) haplotypes are determined by a single-point mutation at codons 112 and 158, respectively.

View Article and Find Full Text PDF

Background: TDP-43 proteinopathy, initially discovered in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), coexists with tauopathy in a variety of neurodegenerative disorders, including Alzheimer's Disease (AD). While such co-pathology is strongly associated with worsened neurodegeneration and steeper cognitive decline, how these two pathologies influence each other to exacerbate neuron loss remains elusive. That loss of TDP-43 splicing repression occurring in presymptomatic ALS-FTD suggests that loss of TDP-43 function could facilitate the pathological conversion of tau to accelerate tauopathy and neuron loss.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!